FDA Approves Ketamine-Like Drug for Severe Depression

WEDNESDAY, March 6, 2019 -- The U.S. Food and Drug Administration on Tuesday approved the nasal spray medication esketamine -- a relative of the club drug and anesthetic ketamine -- for use against severe depression. Sold as Spravato, the...

https://www.drugs.com/news/fda-approves-ketamine-like-severe-depression-80893.ht...

Source: Drugs.com - Pharma News - March 6, 2019 Category: Pharmaceuticals Source Type: news

More News: Anesthesia | Anesthesiology | Depression | Food and Drug Administration (FDA) | Pharmaceuticals